ARTICLE | Clinical News
Ariad preclinical data
May 3, 2010 7:00 AM UTC
In anaplastic lymphoma kinase ( ALK)-dependent non-small cell lung cancer (NSCLC) and anaplastic large cell lymphoma (ALCL) cell lines, AP26113 inhibited ALK with 10-fold greater potency compared to ...